https://www.selleckchem.com/pr....oducts/delamanid.htm
Objectives.To evaluate the tolerability and efficacy of Dermatophagoides pteronyssinus /Dermatophagoides farinae mixture subcutaneous immunotherapy (SCIT). Methods.Patients received an abbreviated build-up schedule. The aims were number, percentage, and severity of adverse reactions. Secondary outcomes included changes in immunoglobulin titers and changes in dose-response skin prick tests. Results.Out of 289 administrations, 17% elicited any clinically relevant adverse reaction. Most of them were local reactions (LR) (9.4%) and the re
إعجاب
علق
شارك
